STOCK TITAN

Crinetics Pharmaceuticals, Inc. (CRNX) Revenue by Year

CRNX

Crinetics Pharmaceuticals, Inc. generated $7.7M in revenue in fiscal year 2025. This represents an increase of 640.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $42.2M in revenue. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Crinetics Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $7.7M
YoY +640.7%
5Y CAGR +155.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRNX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Revenue$42.2M$7.7M+640.7%$1.0M-74.1%$4.0M-15.3%$4.7M+339.4%$1.1M+1418.3%$71K-94.0%$1.2M-50.9%$2.4M+18.7%$2.0M+247.2%$589K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRNX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$25.1M+2336.3%$10.7M+2873.4%$6.2M$143K$1.0M+158.4%$361K-43.6%N/A$0-100.0%$399K-59.6%$640K-76.1%$0-100.0%$346K-24.5%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Crinetics Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Crinetics Pharmaceuticals, Inc.'s revenue in fiscal year 2025?

Crinetics Pharmaceuticals, Inc. generated $7.7M in revenue in fiscal year 2025.

How fast is Crinetics Pharmaceuticals, Inc.'s revenue growing?

Crinetics Pharmaceuticals, Inc. (CRNX) revenue rose by 640.7% year over year, from $1.0M to $7.7M in fiscal year 2025.

What is Crinetics Pharmaceuticals, Inc.'s revenue over the last twelve months?

Crinetics Pharmaceuticals, Inc. (CRNX) reported $42.2M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 10 fiscal years this page covers, Crinetics Pharmaceuticals, Inc. (CRNX) revenue went from $589K in fiscal year 2016 to $7.7M in fiscal year 2025.

Crinetics Pharmaceuticals, Inc. (CRNX) reported $25.1M in revenue in Q2 2026. This represents an increase of 2336.3% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Crinetics Pharmaceuticals, Inc. (CRNX) reported on that line in every period on record.